Lead Product(s): CFTX-1554
Therapeutic Area: Neurology Product Name: CFTX-1554
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: Flanders Innovation & Entrepreneurship
Deal Size: $1.2 million Upfront Cash: Undisclosed
Deal Type: Funding March 30, 2021
The grant covers clinical trial application-enabling studies to further characterize the pharmacology and safety of CFTX-1554 and the development of appropriate manufacturing protocols and translational biomarker studies to examine the mechanism of action of AT2R modulation.